Article de revue
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by tdap brand
The researchers estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide outbreak of pertussis in Wisconsin during 2012 and conclude that their results demonstrate waning immunity following vaccination with either Tdap brand. Boostrix was more effective than Adacel in preventing pertussis in our cohort, but these findings may not be generalizable to adolescent cohorts that received different diphtheria-tetanus-acellular pertussis vaccines (DTaP) during childhood and should be further examined in studies that include childhood DTaP history.
Auteurs
Langues
- Anglais
Année de publication
2014
Journal
J Infect Dis.
Volume
6
Type
Article de revue
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Diphtérie
- Coqueluche
- Tétanos
Pays
- États-Unis
Mots-clés
- Suivi de la couverture
Régions de l'OMS
- Région des Amériques
